$10.06B
Revenue
$2.86B
Net Income
66.00%
Gross Margin
29.27%
Op. Margin
$3.98B
Free Cash Flow
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|---|
| Total Revenue | $2.87B | $2.51B | $2.44B | $2.25B | $2.41B | $2.04B | $2.01B |
| Revenue Growth % (YoY) | 18.8% | 22.9% | 21.4% | nan% | nan% | nan% | nan% |
| Cost of Revenue | $961.90M | $842.70M | $822.10M | $795.70M | $771.30M | $664.20M | $637.20M |
| Gross Profit | $1.90B | $1.66B | $1.62B | $1.46B | $1.64B | $1.37B | $1.37B |
| Gross Margin % | 66.4% | 66.4% | 66.3% | 64.7% | 68.0% | 67.4% | 68.3% |
| Operating Expenses | $1.04B | $902.70M | $874.50M | $879.60M | $907.30M | $796.60M | $805.40M |
| Research & Development | $352.90M | $329.40M | $313.30M | $316.20M | $294.70M | $286.00M | $280.10M |
| Selling General & Admin | $687.10M | $573.30M | $561.20M | $563.40M | $612.60M | $510.60M | $525.30M |
| Operating Income | $864.30M | $759.70M | $743.40M | $578.10M | $734.90M | $577.30M | $567.30M |
| Operating Margin % | 30.2% | 30.3% | 30.5% | 25.7% | 30.4% | 28.3% | 28.2% |
| Other Income/Expense | $91.30M | $95.50M | $88.70M | $90.40M | $74.90M | $93.70M | $87.20M |
| Income Before Tax | $955.60M | $855.20M | $832.10M | $668.50M | $809.80M | $671.00M | $654.50M |
| Income Tax Expense | $156.10M | $146.00M | $167.90M | $-35.20M | $121.80M | $100.40M | $123.00M |
| Net Income | $794.80M | $704.40M | $658.40M | $698.40M | $685.70M | $565.10M | $526.90M |
| Net Margin % | 27.7% | 28.1% | 27.0% | 31.0% | 28.4% | 27.7% | 26.2% |
| Basic EPS | nan | 1.98 | 1.84 | 1.95 | 1.93 | 1.59 | 1.48 |
| Diluted EPS | nan | 1.95 | 1.81 | 1.92 | 1.89 | 1.56 | 1.46 |
| Basic Shares Outstanding | -600K | 356.6M | 358.5M | 357.5M | 400K | 355.8M | 355.0M |
| Diluted Shares Outstanding | -800K | 361.8M | 364.1M | 364.6M | 600K | 362.7M | 361.0M |
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | $3.37B | $2.81B | $3.40B | $2.57B | $2.03B | $2.41B | $3.04B |
| Short-term Investments | $2.57B | $2.10B | $1.92B | $1.94B | $1.99B | $1.82B | $1.72B |
| Accounts Receivable | $1.53B | $1.26B | $1.27B | $1.22B | $1.23B | $1.15B | $1.11B |
| Inventory | $1.84B | $1.78B | $1.67B | $1.55B | $1.49B | $1.48B | $1.38B |
| Other Current Assets | $477.30M | $574.90M | $483.20M | $371.40M | $385.10M | $349.20M | $404.10M |
| Total Current Assets | $9.78B | $8.53B | $8.75B | $7.66B | $7.11B | $7.22B | $7.65B |
| Property Plant & Equipment | $5.34B | $5.15B | $4.99B | $4.80B | $4.65B | $4.43B | $4.12B |
| Goodwill | $370.30M | $348.10M | $348.70M | $347.50M | $347.50M | $348.30M | $348.00M |
| Intangible Assets | $17.10M | - | - | - | $23.00M | - | - |
| Long-term Investments | $3.10B | $3.52B | $4.21B | $4.59B | $4.82B | $4.08B | $2.93B |
| Total Assets | $20.46B | $19.35B | $20.16B | $19.22B | $18.74B | $17.74B | $16.65B |
| Accounts Payable | $255.10M | $291.20M | $266.80M | $276.20M | $193.40M | $218.70M | $194.40M |
| Deferred Revenue | $506.70M | $491.10M | $499.90M | $496.30M | $468.80M | $426.00M | $433.90M |
| Other Current Liabilities | $596.00M | $565.40M | $505.10M | $455.90M | $547.50M | $654.60M | $537.90M |
| Total Current Liabilities | $2.01B | $1.80B | $1.69B | $1.54B | $1.75B | $1.68B | $1.49B |
| Total Liabilities | $2.52B | $2.31B | $2.21B | $2.01B | $2.21B | $2.07B | $1.85B |
| Common Stock | $400.00K | $400.00K | $400.00K | $400.00K | $400.00K | $400.00K | $400.00K |
| Retained Earnings | $7.01B | $6.42B | $7.61B | $7.14B | $6.80B | $6.13B | $5.58B |
| Total Stockholders Equity | $17.82B | $16.93B | $17.85B | $17.11B | $16.43B | $15.58B | $14.71B |
| Total Liabilities & Equity | $20.46B | $19.35B | $20.16B | $19.22B | $18.74B | $17.74B | $16.65B |
| Breakdown | Q4 2025 (Dec 31, 2025) |
Q3 2025 (Sep 30, 2025) |
Q2 2025 (Jun 30, 2025) |
Q1 2025 (Mar 31, 2025) |
Q4 2024 (Dec 31, 2024) |
Q3 2024 (Sep 30, 2024) |
Q2 2024 (Jun 30, 2024) |
|---|---|---|---|---|---|---|---|
| Net Income | $794.80M | $704.40M | $1.36B | $698.40M | $685.70M | $565.10M | $526.90M |
| Stock-based Compensation | $203.30M | $584.90M | $381.40M | $185.20M | $177.00M | $499.80M | $326.90M |
| Change in Receivables | $267.50M | $34.20M | $44.10M | $-3.60M | $74.10M | $21.80M | $-21.00M |
| Change in Inventory | $253.00M | $810.40M | $494.20M | $211.10M | $179.10M | $650.90M | $389.40M |
| Change in Payables | $-39.10M | $97.00M | $72.40M | $83.10M | $-21.60M | $21.20M | $-1.60M |
| Operating Cash Flow | $892.50M | $2.14B | $1.30B | $581.60M | $822.60M | $1.59B | $885.90M |
| Capital Expenditure | $162.50M | $377.30M | $271.90M | $116.60M | $312.00M | $799.20M | $551.30M |
| Acquisitions | $12.70M | $1.20M | $1.20M | - | $1.00M | - | - |
| Purchases of Investments | $425.00M | $790.90M | $691.80M | $519.80M | $1.43B | $3.71B | $1.79B |
| Sales of Investments | $380.00M | $1.80B | $1.19B | $849.90M | $478.80M | $2.40B | $1.64B |
| Investing Cash Flow | $-209.40M | $875.20M | $474.20M | $213.50M | $-1.26B | $-2.01B | $-595.60M |
| Stock Repurchased | $201.00M | $2.09B | $181.00M | - | - | - | - |
| Dividends Paid | - | - | - | - | - | $8.00M | $8.00M |
| Financing Cash Flow | $-137.50M | $-2.23B | $-383.60M | $-235.80M | $49.40M | $101.50M | $3.30M |
| Net Change in Cash | $557.90M | $787.10M | $1.38B | $554.80M | $-383.90M | $-323.80M | $296.70M |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Total Revenue | $2.51B | $2.04B | $7.20B | $5.94B |
| Cost of Revenue | $842.70M | $664.20M | $2.46B | $1.95B |
| Gross Profit | $1.66B | $1.37B | $4.74B | $3.99B |
| Operating Expenses | $902.70M | $796.60M | $2.66B | $2.38B |
| Research & Development | $329.40M | $286.00M | $958.90M | $850.60M |
| Selling General & Admin | $573.30M | $510.60M | $1.70B | $1.53B |
| Operating Income | $759.70M | $577.30M | $2.08B | $1.61B |
| Other Income/Expense | $95.50M | $93.70M | $274.60M | $250.00M |
| Income Before Tax | $855.20M | $671.00M | $2.36B | $1.86B |
| Income Tax Expense | $146.00M | $100.40M | $278.70M | $214.50M |
| Net Income | $704.40M | $565.10M | $2.06B | $1.64B |
| Basic EPS | 1.98 | 1.59 | 5.77 | 4.61 |
| Diluted EPS | 1.95 | 1.56 | 5.67 | 4.53 |
| Basic Shares Outstanding | $356.60M | $355.80M | $357.50M | $354.80M |
| Diluted Shares Outstanding | $361.80M | $362.70M | $363.50M | $361.40M |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $2.81B | $2.03B |
| Short-term Investments | $2.10B | $1.99B |
| Accounts Receivable | $1.26B | $1.23B |
| Inventory | $1.78B | $1.49B |
| Other Current Assets | $574.90M | $385.10M |
| Total Current Assets | $8.53B | $7.11B |
| Property Plant & Equipment | $5.15B | $4.65B |
| Goodwill | $348.10M | $347.50M |
| Long-term Investments | $3.52B | $4.82B |
| Total Assets | $19.35B | $18.74B |
| Accounts Payable | $291.20M | $193.40M |
| Deferred Revenue | $491.10M | $468.80M |
| Other Current Liabilities | $565.40M | $547.50M |
| Total Current Liabilities | $1.80B | $1.75B |
| Total Liabilities | $2.31B | $2.21B |
| Common Stock | $400.00K | $400.00K |
| Retained Earnings | $6.42B | $6.80B |
| Total Stockholders Equity | $16.93B | $16.43B |
| Total Liabilities & Equity | $19.35B | $18.74B |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $704.40M | $565.10M | $2.06B | $1.64B |
| Stock-based Compensation | - | - | $584.90M | $499.80M |
| Change in Receivables | - | - | $34.20M | $21.80M |
| Change in Inventory | - | - | $810.40M | $650.90M |
| Change in Payables | - | - | $97.00M | $21.20M |
| Operating Cash Flow | - | - | $2.14B | $1.59B |
| Capital Expenditure | - | - | $377.30M | $799.20M |
| Acquisitions | - | - | $1.20M | - |
| Purchases of Investments | - | - | $790.90M | $3.71B |
| Sales of Investments | - | - | $1.80B | $2.40B |
| Investing Cash Flow | - | - | $875.20M | $-2.01B |
| Stock Repurchased | - | - | $2.09B | - |
| Dividends Paid | - | - | - | $8.00M |
| Financing Cash Flow | - | - | $-2.23B | $101.50M |
| Net Change in Cash | - | - | $787.10M | $-323.80M |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.
Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.